Id |
Subject |
Object |
Predicate |
Lexical cue |
T55 |
3-6 |
NN |
denotes |
use |
T56 |
7-9 |
IN |
denotes |
of |
T57 |
10-25 |
NNS |
denotes |
corticosteroids |
T58 |
26-29 |
IN |
denotes |
for |
T59 |
30-38 |
NN |
denotes |
COVID-19 |
T60 |
40-41 |
LS |
denotes |
• |
T61 |
43-46 |
NN |
denotes |
IL6 |
T62 |
47-57 |
VBZ |
denotes |
correlates |
T63 |
58-62 |
IN |
denotes |
with |
T64 |
63-71 |
NN |
denotes |
severity |
T65 |
71-72 |
-COMMA- |
denotes |
, |
T66 |
73-84 |
NN |
denotes |
criticality |
T67 |
84-85 |
-COMMA- |
denotes |
, |
T68 |
86-91 |
JJ |
denotes |
viral |
T69 |
92-96 |
NN |
denotes |
load |
T70 |
96-97 |
-COMMA- |
denotes |
, |
T71 |
98-101 |
CC |
denotes |
and |
T72 |
102-111 |
NN |
denotes |
prognosis |
T73 |
112-114 |
IN |
denotes |
of |
T74 |
115-123 |
NN |
denotes |
COVID-19 |
T75 |
125-126 |
IN |
denotes |
• |
T76 |
128-139 |
NNP |
denotes |
Tocilizumab |
T77 |
139-140 |
-COMMA- |
denotes |
, |
T78 |
141-143 |
DT |
denotes |
an |
T79 |
144-152 |
NN |
denotes |
anti-IL6 |
T80 |
152-153 |
-COMMA- |
denotes |
, |
T81 |
154-157 |
MD |
denotes |
can |
T82 |
158-164 |
VB |
denotes |
confer |
T83 |
165-172 |
NN |
denotes |
benefit |
T84 |
173-175 |
IN |
denotes |
in |
T85 |
176-184 |
NNS |
denotes |
patients |
T86 |
185-189 |
IN |
denotes |
with |
T87 |
190-198 |
NN |
denotes |
COVID-19 |
T88 |
199-202 |
CC |
denotes |
and |
T89 |
203-207 |
JJ |
denotes |
high |
T90 |
208-211 |
NN |
denotes |
IL6 |
R51 |
T55 |
T56 |
arg1Of |
use,of |
R52 |
T57 |
T56 |
arg2Of |
corticosteroids,of |
R53 |
T55 |
T58 |
arg1Of |
use,for |
R54 |
T59 |
T58 |
arg2Of |
COVID-19,for |
R55 |
T62 |
T60 |
arg1Of |
correlates,• |
R56 |
T61 |
T62 |
arg1Of |
IL6,correlates |
R57 |
T62 |
T63 |
arg1Of |
correlates,with |
R58 |
T71 |
T63 |
arg2Of |
and,with |
R59 |
T64 |
T65 |
arg1Of |
severity,"," |
R60 |
T66 |
T65 |
arg2Of |
criticality,"," |
R61 |
T65 |
T67 |
arg1Of |
",","," |
R62 |
T69 |
T67 |
arg2Of |
load,"," |
R63 |
T69 |
T68 |
arg1Of |
load,viral |
R64 |
T71 |
T70 |
arg1Of |
and,"," |
R65 |
T67 |
T71 |
arg1Of |
",",and |
R66 |
T72 |
T71 |
arg2Of |
prognosis,and |
R67 |
T72 |
T73 |
arg1Of |
prognosis,of |
R68 |
T74 |
T73 |
arg2Of |
COVID-19,of |
R69 |
T82 |
T75 |
arg1Of |
confer,• |
R70 |
T76 |
T77 |
arg1Of |
Tocilizumab,"," |
R71 |
T79 |
T77 |
arg2Of |
anti-IL6,"," |
R72 |
T79 |
T78 |
arg1Of |
anti-IL6,an |
R73 |
T82 |
T80 |
arg1Of |
confer,"," |
R74 |
T76 |
T81 |
arg1Of |
Tocilizumab,can |
R75 |
T82 |
T81 |
arg2Of |
confer,can |
R76 |
T76 |
T82 |
arg1Of |
Tocilizumab,confer |
R77 |
T83 |
T82 |
arg2Of |
benefit,confer |
R78 |
T82 |
T84 |
arg1Of |
confer,in |
R79 |
T85 |
T84 |
arg2Of |
patients,in |
R80 |
T85 |
T86 |
arg1Of |
patients,with |
R81 |
T88 |
T86 |
arg2Of |
and,with |
R82 |
T87 |
T88 |
arg1Of |
COVID-19,and |
R83 |
T90 |
T88 |
arg2Of |
IL6,and |
R84 |
T90 |
T89 |
arg1Of |
IL6,high |